{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:36:39Z","timestamp":1791149799023,"version":"4.1.0"},"reference-count":0,"publisher":"Wiley","issue":"14","license":[{"start":{"date-parts":[[1993,11,1]],"date-time":"1993-11-01T00:00:00Z","timestamp":752112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[1993,11]]},"abstract":"<jats:p>\n                    We analyzed the status of retinoblastoma and p53 genes in 10 human hepatoma cell lines. Polyclonal anti\u2010peptide antibodies generated against peptides homologous to COOH\u2010terminal and leucine\u2010zipper domains of the retinoblastoma protein allowed us to identify two cell lines (Hep 3B and FOCUS) with abnormal expression. The same cell lines have both lacked p53 expression. In contrast to the retinoblastoma gene, the expression of the p53 gene was abnormal in six additional cell lines. Indeed, only the Hep G2 hepatoblastoma cell line (and its derivative Hep G2\/2215) appeared to have normal p53 and retinoblastoma gene expression. Our studies indicate that p53 abnormalities are common but retinoblastoma gene aberrations are rare in human hepatoma cell lines.\u2014Puisieux, A., Galvin, K., Troalen, F., Bressac, B., Marcais, C., Galun, E., Ponchel, F., Yakicier, C., Ji, J., Ozturk, M. Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines.\n                    <jats:italic>FASEB J.<\/jats:italic>\n                    7: 1407\u20101413; 1993.\n                  <\/jats:p>","DOI":"10.1096\/fasebj.7.14.8224613","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T06:27:06Z","timestamp":1516861626000},"page":"1407-1413","source":"Crossref","is-referenced-by-count":110,"title":["Retinoblastoma and p\n                    <i>53<\/i>\n                    tumor suppressor genes in human hepatoma cell lines"],"prefix":"10.1096","volume":"7","author":[{"given":"Alain","family":"Puisieux","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Oncology Centre Leon Berard Lyon France"},{"name":"Cancer Center Massachusetts General Hospital East Charlestown Massachusetts 02129 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Galvin","sequence":"additional","affiliation":[{"name":"Cancer Center Massachusetts General Hospital East Charlestown Massachusetts 02129 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Troalen","sequence":"additional","affiliation":[{"name":"Service d'Immunologie Moleculaire Institut Gustave Roussy Villejuif France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Bressac","sequence":"additional","affiliation":[{"name":"Cancer Center Massachusetts General Hospital East Charlestown Massachusetts 02129 USA"},{"name":"Service d'Immunologie Moleculaire Institut Gustave Roussy Villejuif France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Marcais","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Oncology Centre Leon Berard Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eithan","family":"Galun","sequence":"additional","affiliation":[{"name":"Cancer Center Massachusetts General Hospital East Charlestown Massachusetts 02129 USA"},{"name":"Liver Unit Hadassah Meditai Center Jerusalem Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederique","family":"Ponchel","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Oncology Centre Leon Berard Lyon France"},{"name":"Cancer Center Massachusetts General Hospital East Charlestown Massachusetts 02129 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cengiz","family":"Yakicier","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Oncology Centre Leon Berard Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Ji","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Oncology Centre Leon Berard Lyon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Ozturk","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Oncology Centre Leon Berard Lyon France"},{"name":"Cancer Center Massachusetts General Hospital East Charlestown Massachusetts 02129 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[1993,11]]},"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fasebj.7.14.8224613","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fasebj.7.14.8224613","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:20:57Z","timestamp":1761693657000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fasebj.7.14.8224613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,11]]},"references-count":0,"journal-issue":{"issue":"14","published-print":{"date-parts":[[1993,11]]}},"alternative-id":["10.1096\/fasebj.7.14.8224613"],"URL":"https:\/\/doi.org\/10.1096\/fasebj.7.14.8224613","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,11]]}}}